title: Noninvasive positive airway pressure and risk of myocardial infarction in acute cardiogenic pulmonary edema: continuous positive airway pressure vs noninvasive positive pressure ventilation.
abstract: BACKGROUND
  The addition of both noninvasive continuous positive airway pressure (n-CPAP) or noninvasive intermittent positive pressure ventilation (n-IPPV) to medical treatment has been shown to improve the outcome of patients with acute cardiogenic pulmonary edema (ACPE). Previous studies indicated a potential risk of new-onset acute myocardial infarction (AMI) associated with the use of n-IPPV. Although further studies did not confirm this observation, a few recent metaanalyses could not eliminate all the doubts at this regards because of the paucity of data available and the presence of confounding factors. This study aims to assess whether the application of n-IPPV, as opposed to n-CPAP, increases the rate of AMI in ACPE patients.
  
  
  METHODS
  Fifty-two patients with severe hypoxemia consequent to ACPE were randomized to receive n-CPAP (n = 27) or n-IPPV (n = 25) in addition to medical therapy. Patients with signs of acute coronary syndrome on hospital admission were excluded from the study. Cardiac markers, ECG, and clinical/physiologic parameters were assessed at study entry, after 30 and 60 min, and every 6 h for the first 2 days.
  
  
  RESULTS
  No significant difference was observed in the rate of AMI (26.9% and 16% with n-CPAP and n-IPPV, respectively, p = 0.244). Rate of intubation (p = 0.481), death (p = 0.662), and hospital stay (p = 0.529) were not different between the two groups. Both techniques were effective in improving gas exchange and vital signs in patients with ACPE.
  
  
  CONCLUSIONS
  The AMI rate was not different with n-CPAP and n-IPPV, which resulted to be equally effective in the treatment of ACPE.
  
  
  BACKGROUND
  Clinicaltrials.gov Identifier: NCT00453947.
authors.affiliation: High Dependency Unit, Ospedale San Giovanni Bosco, Piazza Donatore del Sangue 3 10154 Torino, Italy. giovanni_ferrari@fastwebnet.it
authors.forename: Giovanni
authors.initials: G
authors.lastname: Ferrari
authors.forename: Federico
authors.initials: F
authors.lastname: Olliveri
authors.forename: Giovanna
authors.initials: G
authors.lastname: De Filippi
authors.forename: Alberto
authors.initials: A
authors.lastname: Milan
authors.forename: Franco
authors.initials: F
authors.lastname: Aprà
authors.forename: Adriana
authors.initials: A
authors.lastname: Boccuzzi
authors.forename: Marcella
authors.initials: M
authors.lastname: Converso
authors.forename: Paolo
authors.initials: P
authors.lastname: Navalesi
mesh_terms: D000208:Acute Disease; D000368:Aged; D000704:Analysis of Variance; D015415:Biomarkers / Q000032:analysis; D016009:Chi-Square Distribution; D045422:Continuous Positive Airway Pressure / Q000009:adverse effects; D004562:Electrocardiography; D005260:Female; D006801:Humans; D007558:Italy / Q000453:epidemiology; D008297:Male; D009203:Myocardial Infarction / Q000453:epidemiology*; D011175:Positive-Pressure Respiration / Q000009:adverse effects; D011654:Pulmonary Edema / Q000628:therapy*; D012307:Risk Factors; D018709:Statistics, Nonparametric; D016896:Treatment Outcome
chemical_list: D015415:Biomarkers